Gemcitabine (G) vs gemcitabine-carboplatin (GCB) for patients with advanced non-small cell lung cancer (NSCLC) and PS: 2. A prospective randomized phase II study of the Hellenic Co-Operative Oncology Group
Gemcitabine (G) vs gemcitabine-carboplatin (GCB) for patients with advanced non-small cell lung cancer (NSCLC) and PS: 2. A prospective randomized phase II study of the Hellenic Co-Operative Oncology Group
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2004
Authors:
Kosmidis, PA Dimopoulos, MA Syrigos, C Nicolaides, C Aravantinos, G Boukovinas, I Pectasides, D Bafaloukos, D Karina, M Kalofonos, HP
